These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 1677368)
21. Central and renal hemodynamic effects of a new agonist at peripheral dopamine- and beta-2 adrenoreceptors (dopexamine) in patients with heart failure. Jamison M; Widerhorn J; Weber L; Campese V; Vasquez J; Hovanessian L; Rahimtoola SH; Elkayam U Am Heart J; 1989 Mar; 117(3):607-14. PubMed ID: 2537556 [TBL] [Abstract][Full Text] [Related]
22. Hemodynamic effects of dopexamine in patients following coronary artery bypass surgery. Poelaert JI; Mungroop HE; Koolen JJ; Van den Berg PC J Cardiothorac Anesth; 1989 Aug; 3(4):441-3. PubMed ID: 2577703 [TBL] [Abstract][Full Text] [Related]
23. Haemodynamic effects of different doses of dopexamine hydrochloride in low cardiac output states following cardiac surgery. Friedel N; Wenzel R; Matheis G; Kuppe H; Bittner H; Filcek S; Hetzer R Eur Heart J; 1992 Sep; 13(9):1271-6. PubMed ID: 1356772 [TBL] [Abstract][Full Text] [Related]
24. Use of dopexamine hydrochloride in intensive care patients with low-output left ventricular heart failure. Colardyn FA; Vandenbogaerde JF Am J Cardiol; 1988 Aug; 62(5):68C-72C. PubMed ID: 3407598 [TBL] [Abstract][Full Text] [Related]
25. Enhancing liver blood flow after cardiopulmonary bypass: the effects of dopamine and dopexamine. Sharpe DA; Mitchel IM; Kay EA; McGoldrick JP; Munsch CM; Kay PH Perfusion; 1999 Jan; 14(1):29-36. PubMed ID: 10074644 [TBL] [Abstract][Full Text] [Related]
26. Beneficial haemodynamic effects of intravenous dopexamine in patients with low-output heart failure. Tan LB; Littler WA; Murray RG J Cardiovasc Pharmacol; 1987 Sep; 10(3):280-6. PubMed ID: 2444775 [TBL] [Abstract][Full Text] [Related]
27. Hemodynamic comparison of dopexamine hydrochloride and dopamine in ischemic left ventricular dysfunction. Jackson NC; Taylor SH; Frais MA Am J Cardiol; 1988 Aug; 62(5):73C-77C. PubMed ID: 2457305 [TBL] [Abstract][Full Text] [Related]
28. Dopexamine in congestive heart failure: how do the pharmacological activities translate into the clinical situation? Meinertz T; Drexler H; Just H Basic Res Cardiol; 1989; 84 Suppl 1():177-86. PubMed ID: 2573340 [TBL] [Abstract][Full Text] [Related]
29. Hemodynamic and renal effects of dopexamine and dobutamine in patients with reduced cardiac output following coronary artery bypass grafting. MacGregor DA; Butterworth JF; Zaloga CP; Prielipp RC; James R; Royster RL Chest; 1994 Sep; 106(3):835-41. PubMed ID: 7915979 [TBL] [Abstract][Full Text] [Related]
30. Hemodynamic effects of dopexamine hydrochloride administered by an intracoronary infusion technique. Demeyere R; Flameng W; Lunkenheimer P J Cardiothorac Anesth; 1989 Oct; 3(5 Suppl 1):15. PubMed ID: 2577708 [No Abstract] [Full Text] [Related]
31. Inotropic mechanisms of dopexamine hydrochloride in horses. Muir WW Am J Vet Res; 1992 Aug; 53(8):1343-6. PubMed ID: 1354950 [TBL] [Abstract][Full Text] [Related]
32. [Dopexamine: a new catecholamine used in the treatment of low cardiac output after heart surgery]. Du Grès B; Flamens C Ann Fr Anesth Reanim; 1991; 10(1):21-7. PubMed ID: 1672583 [TBL] [Abstract][Full Text] [Related]
34. [Acute reduction of increased atrial natriuretic peptide level and cyclic guanosine monophosphate in patients with chronic heart failure caused by beta-adrenergic stimulation with dopexamine hydrochloride. Correlation with hemodynamic parameters]. Stangl K; Baumann G; Weil J; Gerzer R; Kerscher M; Blömer H Z Kardiol; 1990 Jun; 79(6):417-23. PubMed ID: 1974099 [TBL] [Abstract][Full Text] [Related]
35. Prolonged infusion of varied doses of dopexamine hydrochloride for circulatory failure after cardiac surgery. Santman FW; Thomas SM; Hoskins B J Cardiothorac Anesth; 1989 Oct; 3(5 Suppl 1):13. PubMed ID: 2577706 [No Abstract] [Full Text] [Related]
36. Hemodynamic comparison of dopexamine and nitroprusside at high and low doses in patients with coronary artery disease and impaired left ventricular function. Ikram H; Foy SG; Low CJ; Redfern SA; Shirlaw TM; Bennett SI; Crozier IG J Cardiovasc Pharmacol; 1995 Nov; 26(5):777-83. PubMed ID: 8637193 [TBL] [Abstract][Full Text] [Related]
37. Acute hemodynamic and neuroendocrine effects of dopexamine, a new vasodilator for the treatment of heart failure: comparison with dobutamine, captopril, and nitrate. Bayliss J; Thomas L; Poole-Wilson P J Cardiovasc Pharmacol; 1987 May; 9(5):551-4. PubMed ID: 2439836 [TBL] [Abstract][Full Text] [Related]
38. Dopexamine unloads the impaired right ventricle better than iloprost, a prostacyclin analog, after coronary artery surgery. Honkonen EL; Kaukinen L; Kaukinen S; Pehkonen EJ; Laippala P J Cardiothorac Vasc Anesth; 1998 Dec; 12(6):647-53. PubMed ID: 9854661 [TBL] [Abstract][Full Text] [Related]
39. Cardiovascular and renal haemodynamic effects of dopexamine: comparison with dopamine. Stephan H; Sonntag H; Henning H; Yoshimine K Br J Anaesth; 1990 Sep; 65(3):380-7. PubMed ID: 1977432 [TBL] [Abstract][Full Text] [Related]
40. [Effect of dopexamine on the hemodynamics of coronary surgery patients with and without bisoprolol blockade]. Günnicker M; Freund U; Grebe EJ; Scherer R; Schieffer M; Zerkowski HR; Hess W Z Kardiol; 1993 Nov; 82(11):729-36. PubMed ID: 7904788 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]